Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.

Pires de Mello CP, Tao X, Kim TH, Vicchiarelli M, Bulitta JB, Kaushik A, Brown AN.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00967-18. doi: 10.1128/AAC.00967-18. Print 2018 Sep.

2.

Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).

Pires de Mello CP, Drusano GL, Rodriquez JL, Kaushik A, Brown AN.

Viruses. 2018 Jun 9;10(6). pii: E317. doi: 10.3390/v10060317.

3.

Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.

Pires de Mello CP, Tao X, Kim TH, Bulitta JB, Rodriquez JL, Pomeroy JJ, Brown AN.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01983-17. doi: 10.1128/AAC.01983-17. Print 2018 Jan.

4.

Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system.

Pires de Mello CP, Drusano GL, Adams JR, Shudt M, Kulawy R, Brown AN.

Eur J Pharm Sci. 2018 Jan 1;111:443-449. doi: 10.1016/j.ejps.2017.10.027. Epub 2017 Oct 25.

5.

Aminomethylnaphthoquinones and HSV-1: in vitro and in silico evaluations of potential antivirals.

Pires de Mello CP, Sardoux NS, Terra L, Amorim LC, Vargas MD, da Silva GB, Castro HC, Giongo VA, Madeira LF, Paixão IC.

Antivir Ther. 2016;21(6):507-515. doi: 10.3851/IMP3039. Epub 2016 Feb 25.

PMID:
26913545
6.

Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.

Pires de Mello CP, Bloom DC, Paixão IC.

Antivir Ther. 2016;21(4):277-86. doi: 10.3851/IMP3018. Epub 2016 Jan 4. Review.

PMID:
26726828

Supplemental Content

Loading ...
Support Center